Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Hematology
•
Antiphospholipid Syndrome
•
Benign Hematology
Do you discontinue warfarin in an APLS patient with calciphylaxis?
Related Questions
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
Do you use direct oral anticoagulants to treat port-a-cath related VTE in patients with an active malignancy?
Does a positive lupus anticoagulant alone confer high enough risk that warfarin is preferred over DOACs in antiphospholipid syndrome?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
Are there any known contraindications or scenarios in which using antifibrinolytics would cause worsening of bleeding symptoms?
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
When would you phlebotomize patients with secondary hemochromatosis, such as due to NAFLD/cirrhosis?
What is the optimal antithrombotic management, if at all, in patients with incidentally identified findings of multiple silent embolic appearing cerebral infarcts?
